Izana Bioscience Ltd.   Report issue

For profit Phase 2
Founded: Oxford United Kingdom (2017)
Status: Defunct (2022)

Organization Overview

First Clinical Trial
2018
NCT03622658
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Izana Bioscience Ltd.